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the seminal vesicles and their mobility relative to the 
prostate corpus.  
Materials and Methods: Based on clinical staging and 
pretreatment MRI scans 3 groups of 30 patients with T2a-
3bN0M0 prostate carcinoma were formed. The first group 
consists of patients with no seminal vesicles invasion . The 
second group had minimal invasion, ≤ 5 mm measured from 
the prostate corpus on the MRI scans. The third group had (>5 
mm ) extensive invasion (figure 1).  
Online fiducial markers registrations were performed in all 
patients on the first 8 cone beam CT scans to establish the 
prostate corpus translational and rotational errors. To 
measure the translational and rotational errors of the seminal 
vesicles, registrations were performed using a 3D shaped 
region of interest of the seminal vesicles and a grey value 
algorithm. Due to poor CBCT quality 106 out of 720 CBCT's 
were excluded. 
The mean and SD residual seminal vesicles displacement was 
calculated for all three groups in LR, CC, AP direction and LR, 
CC, AP rotation. A spearman rho correlation test was 
performed to determine the relation between the invasion 
and the displacement of the seminal vesicles. The 
displacement of the seminal vesicles was compared between 
the groups for all directions using a Mann-Whitney test.  
 
Results: We found a significant reduction in random seminal 
vesicle displacement with increasing tumor invasion in the LR 
(ρ-0.263, p=0,012), CC (ρ-0.297,p=0,04), AP (ρ-0.333, 
p=0,001) direction and for the LR rotation (ρ-0,260, p=0,013). 
The SDs of the residual seminal vesicles displacement were 
significantly different between the group with minimal 
invasion and the group with extensive invasion in the CC and 
AP direction and for the LR rotation, see table 1. Between 
the group with no invasion and the group with extensive 
invasion, a significant difference in residual seminal vesicles 
displacement was found in the LR, CC and AP direction and 
for the LR rotation. No significant differences were found 
between the no invasion group and the minimal invasion 
group. 
 
 
Conclusions: Although increasing tumor invasion in the 
seminal vesicles reduces the mobility of the seminal vesicles, 
the mobility of the seminal vesicles still remains 
considerable, even in case of extensive invasion. Therefore 
strategies, such as adaptive radiotherapy, are needed for 
adequate seminal vesicle coverage despite their reduced 
mobility. 
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Purpose/Objective: Most radiotherapy protocols give some 
flexibility for the Planning Target Volume (PTV) margin to 
each individual centre based on the immobilization devices 
and the Image Guided Radiotherapy (IGRT) protocol. 
Generally, radiation oncology centres have site specific 
guidelines for PTV margins and are not age specific. Factors 
affecting the PTV margin like breathing may differ according 
to the patient age. Applying the same PTV margin for an 
adult and a 3 year old child may not be correct. The aim of 
this work is to evaluate the required PTV margin in paediatric 
and adult patients treated in one centre with similar 
immobilisation and IGRT Protocol.  
Materials and Methods: Thirty nine paediatric patients less 
than 7 years old (23 Brain/Head and Neck, 16 Abdomen) and 
48 adult patients greater than 18 years of age (25 Brain, 23 
Abdomen), were identified. All patients were imaged using 
3D kV Cone Beam CT (CBCT) with minimum of 5 CBCTs. All 
patients were treated radically, planned in the supine 
position with similar immobilization technique between 2012 
and 2014. PTV margin for setup error was calculated in the 
three orthogonal directions (x, y, and z) using the Van Herk 
formula, M=2.5Σ + 0.7σ.  
Results: The required PTV margin for Brain in adult patients 
was 3mm, 2mm and 3mm, while it was 2mm, 2mm and 3mm 
in Brain/ Head and Neck in paediatric patients in the X Y Z 
directions respectively. Regarding the required PTV margin in 
the abdomen region, it was 6mm, 8mm and 6mm in adult 
patients and 6mm, 5mm and 5mm in paediatric patients 
again in the X Y Z directions respectively and the only 
clinically significant difference was in the Y direction in 
treating abdominal cases.  
Conclusions: There is a clinically significant difference in the 
required PTV margin in the Y direction while treating the 
abdomen in paediatric patients. A small difference also exists 
in the Z direction while treating the abdominal region and 
the X direction while treating the Brain/Head and neck 
region. Each department should have separate guidelines for 
paediatric and adult patients regarding the PTV margin 
required for each treatment site. 
 
OC-0080   
Dynamic tumor tracking with the Vero4DRT system using a 
single fiducial marker for early stage lung cancer 
C. Collen1, K. Poels1, T. De Vin1, B. Engels1, M. Boussaer1, G. 
Storme1, D. Verellen1, M. De Ridder1 
1Universitair Ziekenhuis Brussel, Radiotherapy, Brussels, 
Belgium  
 
Purpose/Objective: Dynamic tumor tracking (DTT) requires a 
fiducial as surrogate for tumor position. Clinical results 
applying multiple spherical gold markers, placed around the 
tumor using a bronchoscope, were reported previously (1). 
We report on the use of a single fiducial marker placed inside 
the tumor percutaneously. 
Materials and Methods: A prospective phase II trial was 
initiated using a gimbaled linac for stereotactic radiosurgery 
of early stage lung cancer (NCT 02224547). If tumor motion 
on 4DCT exceeded 8 mm, patients were eligible for DTT and 
a single fiducial marker (Visicoil, IBA, Louvain-la-neuve, 
Belgium) was implanted. Otherwise an internal target volume 
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(ITV) approach was applied. To evaluate the clinical benefit 
of DTT, the tumor motion amplitude on 4DCT was compared 
to the mean maximal peak-to-peak amplitude on fluoroscopy 
sequences acquired during DTT and the difference in PTV 
volume (DTT versus ITV) was calculated. Treatment-related 
toxicity was scored according to the Common Terminology 
Criteria for Adverse Events v.4.0. 
Results: A total of 38 lesions were treated in 35 patients. The 
delivered dose schedules were as follows: 48Gy/4 fractions 
(n=32), 51Gy/3 fractions (n= 4), 60Gy/8 fractions (n=2). Mean 
superior-inferior (SI) motion exceeded 8 mm in 14 out of 38 
lesions. DTT was used for 7 lesions. Reasons for omitting DTT 
were: pulmonary function or lesion location not allowing 
visicoil insertion and history of prior pneumothorax. Mean 
treatment time for a DTT session was 28.6 minutes (20-34.8 
minutes). Mean SI motion on 4DCT in DTT lesions was 11.8 
mm (8.6-16.9 mm). The mean maximal peak-to-peak 
amplitude observed during fluoroscopy was 20.4 mm (8.2-
50.5 mm) demonstraing a significant variability in respiration 
induced tumor motion. DTT achieved a median reduction of 
58% in PTV volume. With a median follow-up of 7 months (3-
19 months), 1 local failure was observed in a centrally 
located lesion treated with an ITV approach. Only 1 patient 
experienced a grade 2 radiation pneumonitis and 2 patients 
presented with a COPD exacerbation in the weeks following 
radiation. No toxicity was observed in the patients treated 
with DTT. 
Conclusions: DTT with the Vero4DRT system using a single 
fiducial marker proved to be clinically feasible and safe. DTT 
can be performed in an acceptable time frame, is able to 
account for respiratory variability and results in a substantial 
reduction in PTV volume.  
(1) Matsuo Y, Ueki N, Takayama K, et al. Evaluation of 
dynamic tumour tracking radiotherapy with real-time 
monitoring for lung tumours using a gimbal mounted linac. 
Radiother Oncol 2014.  
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Purpose/Objective: Background: During the last decade, 
several studies have established predictive models for normal 
tissue radiosensitivity based on multiple SNPs (1-8). 
Typically, these studies assessed a limited number of SNPs. 
For some of these SNPs, a ‘risk allele’ was defined and the 
studies then looked for an association between the total 
number of risk alleles and normal tissue complication risk. 
Even though many of these models have yielded highly 
significant results, the models have often been inconsistent 
with each other (table 1). This probably relates to the way 
these models were constructed. The process had three steps: 
1) For each of the included SNPs, a risk allele (minority vs. 
majority allele) was defined based on the observation that it 
was (often non-significantly) associated with the outcome 
parameter of the study (radiosensitivity). 2) A model was 
established based on these risk alleles. 3) A statistical test 
was carried out to determine if the number of risk alleles was 
significantly associated with radiosensitivity (the same 
parameter as used for the selection of the risk alleles). By 
doing so, a circularity is introduced into the analysis that 
makes it likely that random fluctuations (for the individual 
SNPs) are amplified into significant associations (for the 
entire model). 
Materials and Methods: In order to further explore this 
potential problem, we reanalyzed the dataset originally used 
to establish the multiple SNP model published by Andreassen 
et al. in 2003 (1). Instead of the actual SNP genotypes we 
randomly assigned ‘genotypes’ to the patients for 7 fictitious 
SNPs that had the same relative distribution as the SNPs in 
the original dataset. Subsequently, we selected risk alleles 
for these ‘SNPs’ and established a multiple SNP model 
exactly as in the original study. This procedure was repeated 
10 times.  
Results: In 8 out of 10 times a significant result was found for 
the model. This clearly demonstrates that the process of 
actively fitting the model to the dataset is indeed per se 
capable of producing nominally significant results for the 
entire model. 
Conclusions: Great caution should be taken when a 
predictive model is established and tested within the same 
patient cohort. A significant finding for a multiple SNP model 
established in this way cannot be used to indirectly validate 
the underlying SNPs. Thus, we have to establish robust 
associations for the individual SNPs that can be entered into 
a predictive multiple SNP model that should finally be 
validated in an independent dataset. 
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Purpose/Objective: Rectal bleeding is one of the common 
radiation-induced complications following radiotherapy in 
prostate cancer patients, which can greatly impair the 
quality of life for cancer survivors. The purpose of this study 
was to investigate whether single nucleotide polymorphisms 
(SNPs) are associated with susceptibility to late rectal 
bleeding in men treated with radiotherapy for prostate 
cancer using a genome-wide association study (GWAS) 
dataset. 
